Comprehensive Liver Research Center at UCLA
Accepting 2025 pilot and feasibility award applications
The pilot and feasibility mechanism seeks to fund innovative projects that explore basic-translational mechanisms into the pathophysiology of the MASLD-MASH-cirrhosis-HCC spectrum. The center will support three, 1-year pilot and feasibility awards for a maximum of $25,000 total costs each. Deadline to apply is Sunday, December 15.
Thank you to all our speakers and attendees
Our Inaugural Comprehensive Liver Research Center Symposium was the first of many events to come designed to foster collaborations, learn from scientific experts who conduct liver- and metabolism-related research from around the world, highlight current collaborations and research at UCLA, and promote the work of our junior researchers.
AASLD 2024 Abstracts
Members of the Comprehensive Liver Research Center and David Geffen School of Medicine at UCLA present their latest research at AASLD The Liver Meeting on November 15-19 in San Diego, CA.
Latest news
Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD
“Liver fibrosis is the critical feature that creates chronic liver disease and liver cancer. If we can keep fibrosis in check then we can meaningfully impact liver disease,” said Tamer Sallam, MD, PhD.
Over 4 million US adults with chronic liver disease can be grouped into unique risk groups based on barriers to care
Dr. Carrie R. Wong, the study's lead author on these findings published in the peer-reviewed PLOS ONE, point to the need for interventions aimed at reducing possibly avoidable hospitalizations among the highest-risk people with chronic liver disease.
UCLA scientists receive $9.1 million from the NCI to improve early detection methods for cancer
A liquid biopsy is a promising non-invasive medical test using a small volume of blood that gives scientists insight into the genetic makeup of tumors.